<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>This Popular Weight-Loss Drug Falls Short in Parkinson's Study</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2025/02/07/this-popular-weightloss-drug-falls-short-in-parkinsons-study.aspx</link><description>A recent study has shown that a drug similar to Ozempic, known for its weight-loss benefits, does not help in treating Parkinson's disease. This study, conducted in the United Kingdom, involved 194 people with Parkinson&amp;rsquo;s who received either exenatide</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>